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Introduction
Throughout development, establishment of functional synaptic 
contacts is pivotal for the correct wiring of neurons and ulti-
mately proper brain function in adulthood. Therefore, it is of 
utmost importance to fully comprehend the cascade of events 
comprising synapse formation. One such event, presynap-
tic differentiation, corresponds to the organized clustering of 
presynaptic material in specific locations along the axon (Jin 
and Garner, 2008), which is induced by a cohort of presynaptic 
differentiating proteins, including adhesive or secreted factors 
(Chia et al., 2013). However, the intra-axonal on-site down-
stream events triggering assembly of presynaptic material at 
spots of axodendritic contact are still poorly understood. Con-
trol of protein turnover by the ubiquitin–proteasome system 
(UPS) has been shown to act locally at synapses (Segref and 
Hoppe, 2009), but its involvement in vertebrate presynapse for-
mation is still unknown.
Steady-state levels of ubiquitin (Ub) are required for 
proper synapse formation. The ataxia mice Ups14axJ, with a 
loss-of-function mutation in the deubiquitinase Usp14, display 
severe structural and functional alterations at the neuromus-
cular junction (NMJ; Chen et al., 2009, 2011). These defects 
are completely rescued by restoration of neuronal Ub levels 
(Chen et al., 2009, 2011). A pioneering study in the Drosophila 
melanogaster NMJ concluded that a tight ubiquitination/deu-
biquitination balance is crucial for synapse development, thus 
revealing a role for synaptic ubiquitinated proteins (DiAntonio 
et al., 2001). In fact, ubiquitinated proteins are highly enriched 
at the vicinity of the active zone of Drosophila NMJs (Tian and 
Wu, 2013). Moreover, the presynaptic ubiquitinated proteome 
includes both structural and signaling proteins as well as pro-
teins with known roles in synaptogenesis (Franco et al., 2011; 
Na et al., 2012). Despite the wealth of knowledge on UPS deg-
radation at the synapse, the physiological significance of such a 
complex presynaptic ubiquitinated proteome is far from being 
understood. In the present study, we demonstrate that the UPS 
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acts locally to control the assembly of new presynapses by reg-
ulating accumulation of an on-site pool of polyubiquitinated 
proteins that acts as a hub for presynaptic assembly.
Results and discussion
Inhibition of the proteasome in isolated 
axons has a synaptogenic effect
To understand the axonal intrinsic processes underlying forma-
tion of presynaptic clusters, we relied on microfluidic devices 
for the isolation of axons (Fig. S1 A and Fig. 1 A; Taylor et al., 
2005, 2009; Cristovão et al., 2014; Neto et al., 2014). We used 
this platform to specifically inhibit the proteasome in axons 
with clasto-lactacystin β-lactone or MG132 (Fig. S1, B and C), 
here referred to as local or axonal proteasome inhibition. To 
evaluate the involvement of UPS in presynaptic differentiation, 
we first characterized the time course of presynaptic clustering 
upon local proteasome inhibition. Both MG132 and β-lactone 
caused a robust increase in the density of presynaptic clusters 
that peaked at 1 h with a decrease afterward (Fig. 1, B and C; 
and Fig. S1 D), which is likely caused by disassembly of the 
newly generated orphan presynapses (Yamada et al., 2013). The 
rapid assembly of presynaptic clusters (1 h) is in agreement with 
the proposed time line for synapse formation (Friedman et al., 
2000). We therefore used this time point in subsequent experi-
ments. We validated the clustering specificity of our presynaptic 
phenotype by excluding the possibility of a random increase in 
markers’ total levels caused by less degradation (Fig. S1, E–G).
To detect the appearance of newly formed functional pre-
synaptic terminals upon local proteasome inhibition, we used 
poly-d-lysine (PDL)–coated beads, a synapse-inducing system 
(Lucido et al., 2009) that spatially restricts sites of presynap-
tic differentiation. Indeed, when added to the axonal side, they 
cluster presynaptic material (Taylor et al., 2013), which was en-
hanced by local proteasome inhibition (Fig. S1, H and I). Live 
formation of new active sites on beads (Fig. 1 D) was evaluated 
by repeated cycles of styryl (FM) dye staining (Fig.  1 E), as 
performed elsewhere (Friedman et al., 2000; Shen et al., 2006). 
Proteasome inhibitors increased the number of new FM puncta 
on beads in comparison with vehicle-treated axons (Fig. 1, F 
and G). Approximately half of these new puncta were capable 
Figure 1. Axonal proteasome inhibition boosts formation of presynaptic sites. (A) Microfluidic devices. (B) Local proteasome inhibition by 10 µM β-lactone 
and 1 µM MG132 (box in A) induced an increase in presynaptic clusters (arrowheads), assessed by immunostaining for the SV marker VGluT1 (red) and 
the active zone marker Bassoon (green). (C) Number of presynaptic clusters (colocalized VGluT1 and Bassoon punctum >0.05 µm2) per axonal length 
(percentage of 0 min). Three to five independent experiments. (D and E) Formation of new functional presynaptic sites on beads by repeated cycles of FM 
dye staining. (F) New FM dye puncta (red) appear on beads (dashed circles) after local β-lactone or MG132 treatment (1 h; box in D). (G) Number of 
new total and active FM puncta per bead. n, beads. (H) Synapse formation chambers. (I) Proteasome inhibition in the synaptic compartment (box in H) 
triggered presynaptic assembly (arrowheads) onto dendrites, assessed by presynaptic expression of VGluT1mCherry and staining for MAP2 (blue) and 
Bassoon (green). (J and K) Number of VGluT1mCherry puncta (J) and presynaptic clusters (K) along dendrites per length of transduced axons (percentage 
of control). n, dendrites. (G, J, and K) Three independent experiments. ***, P < 0.001; **, P < 0.01; and *, P < 0.05 compared with 0 min or control and 
###, P < 0.001 and ##, P < 0.01 (Kruskal-Wallis test followed by Dunn’s multiple comparison test). Results are presented as mean values ± SEM. Bars, 5 µm.
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of releasing the dye upon stimulation (Fig. 1 G), thus showing 
that local proteasome inhibition leads to the formation of new 
functional presynaptic sites.
To evaluate the relevance of localized proteasome inhibi-
tion for presynaptic differentiation in an axodendritic synapse, 
we used microfluidic chambers specialized for the compart-
mentalization of synapses (Fig. 1 H; Taylor et al., 2010). The 
excitatory synaptic vesicle (SV) marker VGluT1mCherry was 
presynaptically expressed with axons of transduced neurons 
crossing to the synaptic compartment (Fig. S1 J) and forming 
synaptic contacts with dendrites (Fig. S1, J and K). Proteasome 
inhibition in the synaptic compartment increased the number of 
presynaptic clusters formed on dendrites (Fig. 1, I–K). Analysis 
of VGluT1mCherry-containing presynaptic clusters, whose so-
matodendritic elements were not exposed to treatment, demon-
strates that inhibition of the proteasome in distal axons enhances 
their capability of establishing synapses with a postsynaptic 
partner. Collectively, these results demonstrate a role for pro-
teasome inhibition at the initial stages of presynaptic assembly.
Presynaptic assembly is accompanied by an 
on-site decrease in proteasome activity
We next asked whether contact with a postsynaptic partner in-
duces changes in the rate of proteasome-mediated degradation 
along the axon. To address this question, formation of stable 
presynaptic clusters on beads (Fig. 2) and dendrites (Fig. 3) was 
monitored using live imaging. Neurons in microfluidic devices 
coexpressing VGluT1mCherry (presynaptic reporter) and Ub-
G76VGFP (degradation reporter in which GFP bears a signal for 
rapid ubiquitination and proteasome clearance; Fig. S1 B; Dan-
tuma et al., 2000) extended their axons into the axonal compart-
ment, to which beads were subsequently added (Fig. S2, A and 
B). Upon contact with a bead, axons responded rapidly (20 min) 
with an on-bead increased intensity of the degradation reporter 
that remained elevated, with no detectable changes in adjacent 
(off-bead) segments (Fig. 2, A and B). This bead-specific en-
hancement of UbG76VGFP intensity was not due to increases in 
axonal volume, at least during the first 1 h of contact (Fig. S2, C 
and D). Moreover, FRAP and fluorescence loss in photobleach-
ing (FLIP) on bead-contacting axons indicated that it was not 
solely dependent on diffusion from adjacent regions (Fig.  2, 
D–F) or due to increased retention of the reporter at bead con-
tact sites (Fig.  2, G–I), respectively. Combined, these results 
indicate that local changes in UbG76VGFP are due to decreased 
UPS activity at axonal domains contacting beads. Clustering of 
VGluT1mCherry was later observed at 150 min of bead contact 
(Fig. 2, A and C). Moreover, poststaining for Bassoon revealed 
that its clustering was enhanced on beads that were capable of 
rapidly increasing reporter intensity (Fig. S2, E and F).
We then addressed this issue in axon–dendrite contacts by 
monitoring presynaptic clustering on axons contacting MAP2+ 
structures (Fig. S2, G–I). We quantified changes in the axonal 
degradation rate occurring at the site of a newly formed VGluT1-
mCherry cluster (“new”) in comparison to a preexisting cluster 
(“old”) on dendrites (Fig. 3, A and B). During formation of a 
new stable VGluT1mCherry cluster, there was a significant in-
crease in the ratio of UbG76VGFP intensity between the site of 
clustering and a nonsynaptic adjacent site (UbG76VGFP intensity 
on/off-site ratio; Fig. 3, C and E). Occasional UbG76VGFP ac-
cumulation events accompanied by VGluT1mCherry clustering 
occurred fleetingly but did not form stable clusters. On the con-
trary, no local changes in the degradation reporter signal were 
observed throughout the lifetime of an old puncta (Fig. 3, D and 
F). In conclusion, assembly of an excitatory presynaptic termi-
nal onto a postsynaptic partner is preceded and accompanied by 
a localized reduction in the activity of the proteasome.
Proteasome inhibition-induced presynaptic 
accumulation of ubiquitinated conjugates as 
the trigger for presynaptic differentiation
To unmask the local mechanism generating new presynaptic 
clusters, we first assessed its dependence on protein synthesis 
(Fig. 4 A). The synaptogenic effect of axonal proteasome in-
hibition relied on axonal protein synthesis (Fig. 4 B and Fig. 
S3 A) but not on soma synthesized proteins (Fig. S3, D and E). 
The fact that presynaptic assembly was only reverted when pre-
ceded by long-term (14 h) axonal protein synthesis inhibition 
(Fig. 4 B and Fig. S3 A), in opposition to an acute (1 h) treat-
ment (Fig. S3, B and C), indicated that rapid accumulation of no 
longer degraded proteins from a pool of previously synthesized 
ones underlies the presynaptogenic effect. Interestingly, forma-
tion of sensory-motor synapses in Aplysia californica has also 
been suggested to require local protein synthesis (Lyles et al., 
2006). Nonetheless, the difference in terms of synapse type and 
organisms’ complexity between this study and ours points to 
the possibility of different mechanisms controlling presynaptic 
assembly through local translation.
Because proteasome blocking triggers an extensive ac-
cumulation of ubiquitinated proteins (Fig. S3, J and K) while 
reducing free Ub levels (Fig. S3, H and I), we next wondered 
whether the effect would be dependent on de novo ubiquiti-
nation. We used an inhibitor of the E1 Ub-activating enzyme, 
ziram (Fig. 4 A), which prevents formation of E1–Ub conju-
gates (Rinetti and Schweizer, 2010), and so no degradation of 
nonubiquitinated proteins occurs. Treatment of isolated axons 
with ziram alone had no effect on the number of presynaptic 
clusters, but when in combination with proteasome inhibitors, 
it led to a complete reversion of their clustering effect (Fig. 4 C 
and Fig. S3 F). This result demonstrated that accumulation of 
proteins in their ubiquitinated state is required for local pro-
teasome inhibition-induced presynaptic assembly. To further 
validate this hypothesis, we used a broad-range inhibitor of 
deubiquitinases, PR619 (Fig.  4  A; Altun et al., 2011), which 
expectedly led to an accumulation of ubiquitinated conjugates 
(Fig. S3, J and K). Similar to proteasome inhibitors, PR619 also 
increased the number of presynaptic clusters along axons, yet 
no cumulative effect was observed (Fig. 4 D and Fig. S3 G), 
suggesting that both inhibitors act through the same mecha-
nism. Furthermore, local inhibition of deubiquitination resulted 
in a significant increase in the number of new FM puncta on 
beads (Fig. 4, E and F).
Considering that contact with a postsynaptic partner in-
duced an on-site decreased activity of the proteasome coin-
cident with the moment of presynaptic assembly (Figs. 2, 3, 
and S2), we asked whether ubiquitinated conjugates accumu-
late at sites of newly formed presynaptic clusters. Lysine 48 
(K48)–linked polyUb chains on substrates function as tags for 
proteasomal degradation (Thrower et al., 2000) and as such, 
undergo robust up-regulation upon proteasome inhibition (Fig. 
S3, L and M; Xu et al., 2009). Staining cultures with an anti-
body specific for K48 polyUb chains (Apu2; Newton et al., 
2008) revealed a pronounced concentration of K48 Ub signals 
in newly formed presynaptic clusters as opposed to a diffuse 
pattern in control conditions (Fig. 4, G and H). Interestingly, 
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synaptic expression of K48 Ub chains is higher at develop-
mental stages coincident with the peak of synaptogenesis in 
the hippocampus (Fig. 4 I; Mody et al., 2001), which recapitu-
lates the pattern observed in whole brain extracts (Chen et al., 
2011). Moreover, contact with beads induces accumulation of 
K48 polyubiquitinated proteins in the contacting axon (Fig. 4, 
J and K). Altogether, these results demonstrate that polyubiq-
uitinated conjugates bearing the K48 polyUb tag accumulate at 
nascent presynaptic sites.
Collectively, this set of data suggests that accumulation of 
polyubiquitinated conjugates at the site of a nascent presynapse, 
in response to a local halt in proteasome degradation, functions 
as the trigger for presynaptic clustering.
A role for proteasome-related polyUb 
chains in presynaptic assembly
Polyubiquitination can occur at any of the lysines present in 
Ub 6, 11, 27, 29, 33, 48, and 63 (Peng et al., 2003), with dis-
tinct biological outcomes (Sadowski et al., 2012). Although 
K48 and K11 polyubiquitination triggers proteasome degrada-
tion, K63 Ub chains have a role in nondegradative pathways 
in cells (Fig.  5  A; Sadowski et al., 2012). We further tested 
our working hypothesis by generating Sindbis virus expressing 
wild-type (wt) and mutant forms of Ub that prevent polyubiq-
uitination onto specific lysines by their mutation into arginine 
(UbK11R, UbK48R, and UbK63R; Fig. 5 A and Fig. S3, N–S). 
Expression of wtUb in neurons cultured in microfluidic devices 
Figure 2. Rapid increase in the degradation reporter intensity on beads precedes clustering. (A) Bead contact (dashed circles) rapidly increased the inten-
sity of UbG76VGFP (firelut and green) with later clustering of VGluT1mCherry (red), not observed in off-bead sites (solid circles). (B and C, left) UbG76VGFP 
(B) and VGluT1mCherry (C) intensities at on- and off-beads throughout time (normalized to time 0, dashed line). ***, P < 0.001; **, P < 0.01; and *, 
P < 0.05 for on- versus off-bead (two-way ANO VA). n, beads and equivalent off-sites. (B and C, right) Values at time 0 and 150 min. ***, P < 0.001 
(Wilcoxon paired t test). (D and G) Dynamics of UbG76VGFP accumulation on beads (circles) by FRAP (D) and FLIP (G) at off-bead sites and on-bead sites 
without or with enhanced local intensity of UbG76VGFP (arrows indicate bleaching). (D) Recovery after FRAP (boxes) is not complete at beads with enhanced 
reporter intensity. (G) Fluorescence loss (green boxes) after FLIP (gray boxes) is almost complete in all conditions. (E and H) Mean changes in UbG76V-GFP 
fluorescence after FRAP (E) and FLIP (H). incr., increase. Control ROIs, brownish traces. (E) FRAP ROI, greenish traces. Time constant (τ) does not differ, 
showing unaltered speed of recovery (off-bead, τ = 4.1 ± 0.4; on-bead without UbG76V-GFP, τ = 5.4 ± 1.0; on-bead with UbG76V-GFP, τ = 6.2 ± 0.6). n 
= 20–32. (H) FLIP ROI, grayish traces; analysis ROI, greenish traces. n = 27–32. (F) Percent UbG76V-GFP recovery after FRAP caused by diffusion from 
adjacent regions. (I, left) Percentage of UbG76V-GFP–retained fraction after FLIP in adjacent regions. (I, right) Mean time constant (in seconds) shows slower 
rate of fluorescence loss from beads with enhanced UbG76V-GFP. ns, not significant. (F and I) ***, P < 0.001 (Kruskal-Wallis test followed by the Dunn’s 
multiple comparison test). n, events. (A–I) Three independent experiments. Results are presented as mean values ± SEM. Bars, 5 µm.
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strongly increased the number of presynaptic clusters (Fig. 5, 
B and C; and Fig. S3, T–V) and the number of total and func-
tional FM puncta along dendrites (Fig. 5, D and E; and Fig. 
S3 W), which were suppressed by prevention of K11 and K48 
polyubiquitination, as opposed to K63. We thus concluded that 
up-regulation of polyubiquitinated conjugates upon expression 
of Ub triggers presynaptic assembly. Interestingly, Ub chains 
with expected roles in proteasome degradation (K11 and K48) 
were required. Both proteasome inhibition and prevention of 
protein polyubiquitination reduce global protein degradation. 
The difference resides in the state of the substrates being ac-
cumulated: polyubiquitinated versus mono- or nonubiquiti-
nated. Accordingly, the lack of synaptogenic effect of UbK48R 
(or UbK11R) further supports the hypothesis that the effect 
of proteasome inhibitors is attributed to the remaining pool 
of polyubiquitinated substrates. We hereby demonstrate that 
K11- and K48-polyubiquitinated proteins are the triggers for 
presynaptic formation.
Figure 3. On-site decreased proteasome ac-
tivity during formation of stable VGluT1 clusters 
on dendrites. (A–D) VGluT1mCherry puncta on 
MAP2+ structures were grouped as “new” (A and 
C) or “old” (B and D). (C) Increased intensity of 
UbG76VGFP at the site of clustering (on-site, dashed 
box) during formation of a new VGluT1mCherry 
cluster, not observed throughout the lifetime of 
an old cluster (D). Solid box, off-site. (E and F, 
left) Time courses of on-site (red line) and off-site 
(brown line) VGluT1mCherry intensity normalized 
to time 0 and the on/off-site ratio of UbG76VGFP 
intensities (green line) for "new" (E) and "old" 
(F) clusters. For E and F, time 0 corresponds to 
the frame preceding clustering (dashed line) and 
the beginning of the time-lapse. VGluT1mCherry 
(red): #, P < 0.05 for on- versus off-site (***, P 
< 0.0001, two-way ANO VA). UbG76VGFP ratio 
(green): ***, P < 0.0001 (Kruskal-Wallis test). (E 
and F, right) On/off-site ratio of UbG76VGFP intensi-
ties at specific time points. *, P < 0.05 in compari-
son to −40 min (Kruskal-Wallis test followed by the 
Dunn’s multiple comparison test). n, clusters. Three 
independent experiments. Results are presented as 
mean values ± SEM. Bars, 5 µm.
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A proteasome inhibition-derived polyUb 
nest for presynaptic assembly
In this study, we unmask a new on-site UPS-related mechanism 
controlling formation of presynaptic sites. Our results suggest 
a model in which transient and local reduction of proteasome 
activity after contact with a postsynaptic partner leads to an on-
site accumulation of proteins in their polyubiquitinated state 
(K48 and K11), which in turn functions as a nesting platform 
for the clustering of presynaptic material and subsequently, pre-
synaptic differentiation (Fig. 5 F).
Developmental regulation of the UPS controls presynaptic 
formation. In the rat brain, activity of proteasome catalytic sub-
units is high at the first postnatal week with subsequent reduction 
(Petersen et al., 2010). Also, UPS components are up-regulated 
at this developmental stage, and high concentrations of K48-
tagged proteins are observed (Chen et al., 2011). Moreover, in 
Figure 4. Presynaptic accumulation of ubiquitinated conjugates is required and sufficient to induce presynaptic assembly. (A) Selective targeting of UPS 
and protein synthesis. (B–D) Density of presynaptic clusters (percentage of control) after axonal proteasome inhibition in the absence or presence of protein 
synthesis inhibitors emetine (10 µM) or anisomycin (10 µM; B), ziram (1 µM; C), or PR619 (1 µM; D). Long-term (14 h) inhibition of axonal protein synthesis 
(B) and inhibition of E1-mediated ubiquitination (1 h; C) abolished the synaptogenic effect of proteasome inhibition. (D) PR619 locally boosted formation of 
clusters. Five independent experiments. ns, not significant. (E) PR619 led to an increase in the formation of FM puncta on beads (dashed circles; protocol; 
Fig. 1, D and E). (F) Number of new total and active FM puncta per bead. ***, P < 0.001; *, P < 0.05 (Mann-Whitney test). (G) Accumulation of K48 
polyUb (red) signal on presynaptic clusters by axonal proteasome and deubiquitinases inhibition. (H) Quantification of G (percentage of control). Four inde-
pendent experiments. (I) Representative immunoblot of synaptosomal K48 Ub chains shows up-regulation at early postnatal development. Tubulin, loading 
control. (J) Axonal accumulation of K48 polyUb conjugates on beads (dashed circles; 4–5 h on the axonal side). Solid circles indicate off-bead. (K) K48 
Ub intensity (normalized to off-bead). ***, P < 0.001 (Wilcoxon paired t test). (B, C, D, and H) ***, P < 0.001; **, P < 0.01; and *, P < 0.05 compared 
with control and ###, P < 0.001; ##, P < 0.01; and #, P < 0.05 (Kruskal-Wallis test followed by the Dunn´s multiple comparison test). n, microscope FOVs. 
(F and K) n, beads. Three independent experiments. Results are presented as mean values ± SEM. Bars, 5 µm.
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the Drosophila embryo, K48 and K11 Ub chains represent 57% 
and 11%, respectively, of the neuronal ubiquitome (Franco et al., 
2011). These studies show that at the peak of synaptogenesis, 
the UPS is highly active. Somewhat similar to the effect on sen-
sory synaptic inputs in A. californica motoneurons (Zhao et al., 
2003), we show enhanced presynaptic assembly upon local pro-
teasome inhibition. Hence, one can speculate that in the young 
brain, high proteasome activity acts as a brake on the formation 
of presynaptic sites, which will be relieved upon spatiotempo-
ral reduction. The idea that local decreased proteasome activity 
dictates the onset of synaptogenesis implies that the developing 
axon has ways of promoting endogenous proteasome inhibition. 
Indeed, dynamic modifications can alter proteasome activity in 
neurons (Upadhya et al., 2006; Djakovic et al., 2009; Tai et al., 
2010; Caldeira et al., 2013; Huang et al., 2013); however, this 
has yet to be linked to presynaptogenic cues. Contradictorily, in 
Caenorhabditis elegans axons, the extent of presynaptic differ-
entiation is controlled by localized function of E3 ligases, either 
by removing kinases that suppress synaptogenesis (Liao et al., 
2004; Nakata et al., 2005) or by eliminating unwanted terminals 
(Ding et al., 2007). These studies reveal a role for enhanced pro-
teasome clearance in the control of nascent presynapses, which 
together with our results indicate that UPS may govern synapse 
formation in diverse ways.
In this study, we gathered a substantial set of data demon-
strating that formation of presynaptic clusters is triggered by an 
on-site accumulation of polyubiquitinated proteins. Interestingly, 
the two types of chains known to target proteins for degradation 
(K11 and K48; Thrower et al., 2000; Kravtsova-Ivantsiv and 
Ciechanover, 2012) were identified as the prime signals. So far, 
few studies have revealed roles for K48 and K11 Ub chains other 
than this classical labeling (Ye et al., 2003; Flick et al., 2004; 
Dynek et al., 2010; Goto et al., 2010; Hay-Koren et al., 2011). 
Herein, we propose a novel role for these two types of Ub link-
ages in signaling presynaptic assembly. In agreement, various 
presynaptic proteins are known to be ubiquitinated (Segref and 
Hoppe, 2009; Bingol and Sheng, 2011; Franco et al., 2011; Na 
et al., 2012). Future efforts should be directed at identifying the 
polyubiquitinated local players instructing presynaptic forma-
tion. We predict these might be presynaptic scaffolds or elements 
of the axonal cytoskeleton machinery, which are currently be-
lieved to scaffold nascent presynapses (Chia et al., 2013). We fur-
ther hypothesize that transient enrichment of proteasome-related 
polyubiquitinated proteins may act as a hub for the recruitment 
Figure 5. K48 and K11 polyubiquitination triggers formation of presynaptic sites. (A) Altering levels of endogenous polyUb chains by overexpressing 
wt and mutant Ub. (B and D) wtUb led to increased presynaptic clusters in isolated axons (B) and FM puncta along dendrites (MAP2, blue; D), which 
did not occur for UbK11R and UbK48R mutants. eGFP, control. Bars, 5 µm. (C) Number of presynaptic clusters per axonal length (percentage of eGFP). 
n, microscope FOVs. Five independent experiments. (E) Number of functional FM puncta per dendritic length (normalized to eGFP). n, dendrites. Two 
individual experiments. (F) Current model: a proteasome inhibition-derived polyUb nest for presynaptic assembly. PTV, piccolo-Bassoon transport vesicle. 
***, P < 0.001; **, P < 0.01; and *, P < 0.05 compared with eGFP (Kruskal-Wallis test followed by the Dunn’s multiple comparison test). Results are 
presented as mean values ± SEM.
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of SV protein transport vesicles and piccolo-Bassoon transport 
vesicles and formation of en passant boutons (Fig. 5 F). Analo-
gously, some strategies for DNA repair involve recruitment of 
repair machinery to the site of DNA lesion by the recognition of 
loci of extensively ubiquitinated histones (Jackson and Durocher, 
2013). Also, activation of the NF-κB pathway requires recruit-
ment of kinases to a highly polyubiquitinated signaling complex 
formed by activation of transmembrane receptors (Kulathu and 
Komander, 2012). This study opens the exciting question of how 
a pool of polyubiquitinated conjugates functions as an intracel-
lular signal to presynaptic assembly. Furthermore, we anticipate 
the need to identify the axonal machinery responsible for the 
recognition and decoding of these polyUb signals.
Materials and methods
Constructs
F(syn)WRBN-VGluT1mCherry, a vector for lentiviral expression of a 
fusion version of VGluT1 to mCherry, was provided by E. Herzog (In-
terdisciplinary Institute for Neuroscience, Bordeaux, France; Herzog et 
al., 2011). The VGluT1mCherry coding sequence was amplified by PCR 
(primers 5′-CCA CCT CTA GAC GCG TGC CGC CGC CAT GGA GTT 
CCG GCA GGA GGA GTT-3′ and 5′-CTG GTC GGA TCA TTG GGC CCT 
TAC TTG TAC AGC TCG TCC ATG CCG-3′) and cloned into pSinRep5 
vector (Invitrogen) through ApaI and MluI sites by a cloning kit (639648; 
In-Fusion HD; Takara Bio Inc.), so that a Sindbis viral expression ver-
sion of this fusion protein was generated. The degradation reporter Ub-
G76VGFP (plasmid 11941; Addgene; Dantuma et al., 2000) and GFP-Ub 
(plasmid 11928; Addgene) were provided by C. Duarte (University of 
Coimbra, Coimbra, Portugal). To generate a plasmid for Sindbis viral–
mediated expression of the degradation reporter, the UbG76V-GFP coding 
sequence was amplified by PCR (primers 5′-CCA CCT CTA GAC GCG 
TGC CGC CGC CAT GCA GAT CTT CGT GAA GAC TCTG-3′ and 5′-
CTG GTC GGA TCA TTG GGC CCT TAC TTG TAC AGC TCG TCC ATG 
CCG AGA GT-3′) and cloned into pSinRep5 vector through ApaI and 
MluI sites by the cloning kit. To generate a Sindbis viral construct for 
the expression of Ub, the coding sequence of the wtUb was amplified 
from GFP-Ub by PCR (primers 5′-CAC CAC CAC CTC TAG ACG GGC 
CGC ATG CAG ATC TTC GTG AA-3′ and 5′-AGG GGC GGA ATC TAG 
ATC ACC CAC CTC TGA GAC GGA GTAC-3′) and cloned into pSinRep-
IRES-eGFP vector (provided by U. Hengst, Columbia University, New 
York, NY; Wu et al., 2005) through the XbaI site by the cloning kit. In 
the resulting plasmid, pSinRep-wtUb-IRES-eGFP, the expression of Ub 
is under control of the subgenomic promoter, whereas eGFP expression 
is controlled by a ribosome entry site (IRES). The empty vector pSin-
Rep-IRES-eGFP was used as the control. Site-directed mutagenesis to 
the coding sequence of Ub inserted into the pSinRep-wtUb-IRES-eGFP 
plasmid was performed by a site-directed mutagenesis kit (200521; Qui-
kChange II XL; Agilent Technologies). Lysines in positions 11, 48, and 
63 of Ub sequence were mutated to arginine to generate the Ub mutant 
forms UbK11R (primers 5′-GAA GAC TCT GAC TGG TAG GAC CAT 
CAC CCT CGA-3′ and 5′-TCG AGG GTG ATG GTC CTA CCA GTC AGA 
GTC TTC-3′), UbK48R (primers 5′-AGA GGC TGA TCT TTG CTG GAA 
GAC AGC TGG AAGA-3′ and 5′-TCT TCC AGC TGT CTT CCA GCA 
AAG ATC AGC CTCT-3′), and UbK63R (primers 5′-CCT GTC TGA CTA 
CAA CAT CCA GAG AGA GTC CAC CCT-3′ and 5′-AGG GTG GAC TCT 
CTC TGG ATG TTG TAG TCA GAC AGG-3′), respectively.
Antibodies
We used the following primary antibodies: mouse monoclonal Bassoon 
(1:400, immunocytochemistry [ICC]; 1:1,000, Western blot [WB]; 
ADI-VAM-PS003; Enzo Life Sciences), rabbit monoclonal K48 polyUb 
(Apu2; 1:500, ICC; 1:1,000, WB; 05-1307; EMD Millipore), chicken 
polyclonal MAP2 (1:5,000, ICC; AB5543; EMD Millipore), chicken 
polyclonal tau (1:1,000, ICC; ab75714; Abcam), mouse monoclonal tu-
bulin (1:300,000, WB; T7816; Sigma-Aldrich), mouse monoclonal tuj1 
(1:1,000, ICC; MMS-435P; Covance), rabbit polyclonal Ub (1:200, 
ICC; 1:1,000, WB; Z0458; Dako), guinea pig polyclonal VGluT1 
(1:1,500, ICC; AB5905; EMD Millipore), and rabbit polyclonal 
VGluT1 (1:5,000, WB; 135503; Synaptic Systems). As for secondary 
antibodies, alkaline phosphatase–conjugated antibodies (Jackson Im-
munoResearch Laboratories, Inc.) were used for blotting, and Alexa 
Fluor 350–, 488–, 568–, and 647–conjugated antibodies (1:1,000; 
Thermo Fisher Scientific) were used for immunocytochemistry.
Microfluidic devices for neuron culture
Microfluidic devices consist of a molded polydimethylsiloxane 
(PDMS) chamber assembled in a glass coverslip (Taylor et al., 2003). 
The molds for the PDMS devices used in this study were fabricated 
by N.L.  Jeon. Microfluidic devices were prepared and assembled 
similarly to those previously described (Taylor et al., 2005). In brief, 
PDMS was prepared from a silicon elastomer kit (Sylgard 184; Dow 
Corning) and cured in molds, and each device was properly cleaned, 
sterilized with 75% ethanol, and air dried in the culture hood. Glass 
coverslips (Assistent) were cleaned in 65% nitric acid and extensively 
washed with mQH2O (five washes for 30 min each), rinsed twice in 
100% ethanol, dried, and sterilized under UV radiation for at least 15 
min. The PDMS mold was properly assembled on the glass coverslip 
under sterile conditions. Coverslips were double coated with PDL (0.1 
mg/ml overnight at 37°C) and laminin (2 µg/ml for 2 h at 37°C). Before 
plating cells, devices were washed once with plating medium (MEM 
supplemented with 0.026 M NaHCO3, 0.025 M glucose, 1 mM sodium 
pyruvate, and 10% FBS).
Primary culture of hippocampal neurons
Primary cultures of rat hippocampal neurons were prepared as previ-
ously described (Baptista et al., 2010; Baeza et al., 2012), with minor 
changes. After dissection, hippocampi from E18 Wistar rat embryos 
were dissociated in 0.045% trypsin/0.01% vol/vol deoxyribonuclease 
in HBSS for 15 min at 37°C. Hippocampi were then washed once in 
plating medium containing 10% FBS, thus stopping trypsin activity, 
and mechanically dissociated in fresh plating medium, and cell density 
was determined. Cells were plated in plating medium: in 450-µm mi-
crofluidic devices, 7 × 104 cells were plated in the somal compartment; 
in synapse formation chambers, 7 × 104 and 105 cells were plated in 
the presynaptic and postsynaptic compartment, respectively. Neurons 
were allowed to attach for 2–4 h, and then plating medium was replaced 
with culture medium (neurobasal medium supplemented with 2% B27, 
25 µM glutamate, 0.5 mM glutamine, and 1:400 penicillin/streptomy-
cin). In microfluidic devices, as a way of reducing glutamate excitotox-
icity in growing axons, glutamate-free culture medium was added to 
the axonal compartment of 450-µm microfluidic devices and to the syn-
aptic compartment of synapse formation chambers. Cells were main-
tained in a humidified incubator with 5% CO2/95% air at 37°C. At day 
in vitro (DIV) 3/4, the mitotic inhibitor 5-fluorodeoxyuridine (10-µM 
final concentration) was added to reduce contamination with glia cells. 
Cells were allowed to grow, and, unless otherwise indicated, experi-
ments were performed at DIV 7/8, which corresponds to the peak of 
synaptogenesis in primary hippocampal cultures (Fletcher et al., 1994).
Synaptosome preparation
Purification of synaptosomes was performed as previously described 
(Ribeiro et al., 2014). Hippocampi from Wistar rats (P3, P7, and adult) 
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were dissected and homogenized in a motor-driven glass Teflon homog-
enizer (30 stokes and 900 rpm at 4°C) in Hepes-buffered sucrose buffer 
(0.32 M sucrose and 4 mM Hepes, pH 7.4) supplemented with prote-
ase and phosphatase inhibitors (0.2 mM PMSF, 1 µg/ml chymostatin/ 
leupeptin/antipain/pepstatin, 0.1 mM sodium ortovanadate [Na3VO4], 
and 50 mM NaF). The homogenate was then centrifuged at 900 g for 
15 min at 4°C, and the supernatant was collected and centrifuged at 
18,000 g for 15 min at 4°C to yield the synaptosomal fraction. It was 
further washed by resuspension in Hepes-buffered sucrose buffer and 
centrifugation at 18,000  g for 15 min at 4°C.  Quantification of pro-
tein was performed by the bicinchoninic acid assay, and 40-µg samples 
were denatured with denaturating buffer (62.5 mM Tris-HCl, pH 6.8, 
10% vol/vol glycerol, 2% vol/vol SDS, 0.01% weight/vol bromophenol 
blue, and 5% vol/vol β-mercaptoethanol, added fresh) and boiled at 
95°C for 5 min before running the WB.
Generation of Sindbis and lentivirus
For the generation of Sindbis virus, the pSinRep construct expressing 
the desired gene of interest and the helper plasmid DH26S were lin-
earized with either XhoI, PacI, or NotI and properly treated for the 
removal of RNase contamination. Synthesis of RNA from linearized 
DNAs was performed by in vitro transcription using the mMES SAGE 
mMAC HINE SP6 kit (1340; Ambion). BHK-1 cells were electropo-
rated with 12 µg DH26S RNA and 12 µg of the desired pSinRep RNA, 
and production of virus was allowed to occur for 24–36 h. Supernatant 
was then collected, and virus particles were purified by centrifugation 
at 60,000 g for 2 h and 20 min at 15°C. The viral pellet was then resus-
pended in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 
1.8 mM KH2PO4, pH 7.4) with 0.1% BSA and stored at −80°C. The 
virus titer was determined in BHK-1 cells, and the volume of virus for 
infection was adjusted so that >85% of neurons were transduced. For 
expression of Ub and its mutant forms in microfluidic devices, expres-
sion was allowed to occur for 18–20 h. For live-imaging experiments, 
cells were incubated with virus for 6–8 h before imaging.
For the generation of lentivirus, HEK293T cells were transfected 
using calcium phosphate transfection with the lentiviral expression 
vector F(syn)WRBN-VGluT1mCherry and three lentiviral packaging 
vectors, pLP1, pLP2, and pLP-VSVG, for the expression of gag/pol 
genes, rev gene, and VSVG envelope glycoprotein gene, respectively. 
The supernatant containing virus particles was collected 48–60  h 
after transfection and concentrated by centrifugation at 60,000  g 
for 2  h at 22°C.  The viral pellet was then resuspended in PBS with 
0.1% BSA and stored at −80°C.  After infection, expression of pro-
tein occurred for 48–60 h.
PDL-coated beads
Aliphatic amine latex beads were prepared as previously described 
(Taylor et al., 2013). They were incubated with PDL for 30 min at 
37°C, centrifuged to remove supernatant, washed twice in sterile 
mQH2O, and diluted in culture medium. 30 µl of bead suspension was 
added to the axonal compartment of microfluidic devices and incu-
bated at 37°C for the indicated period of time. For live-imaging experi-
ments, beads were diluted in Hepes-buffered solution imaging medium 
(119 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM glu-
cose, and 10 mM Hepes, pH 7.4).
Drug treatment
Treatment of cells with UPS or protein synthesis inhibitors was per-
formed in conditioned medium. For proteasome inhibitors, a preincu-
bation of 30 min and 15 min was performed with β-lactone and MG132, 
respectively. When cells were cotreated with proteasome inhibitors 
and protein synthesis inhibitors PR619 or ziram, both inhibitors were 
added simultaneously. All inhibitors were diluted in conditioned me-
dium from a 1,000× stock in DMSO and added to cells, except for the 
protein synthesis inhibitors emetine and anisomycin, which were di-
luted in mQH2O. Equal amounts of DMSO or water were added to the 
control. β-Lactone, emetine, and anisomycin were applied at 10 µM. 
As for MG132, PR619, and ziram, a concentration of 1 µM was used.
Biochemistry
Biochemical analysis of protein levels was performed by WB as pre-
viously described (Shin et al., 2010; Baptista et al., 2014), with minor 
changes. Cells were first washed twice in cold PBS. Protein extracts 
were then prepared by scrapping cells in radioimmunoprecipitation 
assay lysis buffer (150  mM NaCl, 50  mM Tris-HCl, pH 7.4, 5  mM 
EGTA, 1% Triton X-100, 0.5% deoxycholate, and 0.1% SDS, pH 7.5, 
freshly supplemented with 50  mM NaF, 1.5  mM Na3VO4, 0.1  mM 
PMSF, and 1 µg/ml chymostatin/leupeptin/antipain/pepstatin). Lysates 
were sonicated and centrifuged at 16,100 g for 10 min at 4°C, and the 
supernatant was collected. Quantification of protein was performed by 
the bicinchoninic acid assay, and samples (40 µg in 40 µl) were dena-
tured with denaturating buffer and boiled at 95°C for 5 min. Protein ex-
tracts were electrophoresed in a Tris-glycine-SDS buffer (25 mM Tris, 
192  mM glycine, and 0.1% weight/vol SDS, pH 8.3) in 7.5% (Bas-
soon and VGluT1), 15% (free Ub), or 4–15% gradient (ubiquitinated 
conjugates with Ub and Apu2 antibodies) polyacrylamide gel 1.5 mm 
thick. Electrotransfer onto a polyvinylidene difluoride membrane was 
performed either overnight at 40 V at 4°C or by using an equivalent 
protocol for rapid transfer (250 mA for 4 h or 250 mA for 6 h at 4°C 
depending on the protein of interest weight). Membranes were washed 
once with TBS (20 mM Tris and 137 mM NaCl) with 0.1% vol/vol 
Tween 20 (TBS-T) and blocked for 1 h at RT in TBS-T with 5% nonfat 
dry milk or 3% BSA. Membranes were again washed for three times 
with TBS-T and incubated with the primary antibody diluted in TBS-T 
containing 5% or 0.5% weight/vol nonfat dry milk or 3% BSA. Incu-
bation was performed either overnight at 4°C or at RT for 1 h. After 
three washes, membranes were incubated for 1 h with alkaline phos-
phatase–conjugated secondary antibodies (anti-mouse or anti-rabbit, 
depending on the primary antibody host species) at RT, washed again 
for three times, and resolved with enhanced chemifluorescence sub-
strate for a maximum of 5 min. Membranes were scanned with a gel 
and blot imaging system (Storm 860; GE Healthcare), and quantifica-
tion was performed using ImageQuant software under linear exposure 
conditions. Whenever necessary, membranes were stripped with 0.2 M 
NaOH for 20 min and reprobed.
Live-cell imaging
Live-imaging experiments for fluorescently tagged proteins (eGFP and 
mCherry; excitation wavelength of 488 and 561 nm) and for the FM 
5-95 lypophilic styryl dye (T23360; Thermo Fisher Scientific; excitation 
wavelength of 560 nm) were performed at RT (∼20°C) in imaging me-
dium (119 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM 
glucose, and 10 mM Hepes, pH 7.4). Acquisition was performed using 
a spinning disk confocal imaging system (CSU-X1-M1N-E; Yokogawa 
Electric Corporation) configured for a motorized inverted microscope 
(IX81; Olympus) driven by iQ 3.1 software (Andor Technology). Im-
ages were collected with a 60× water objective (1.2 NA; UPL SAPO; 
Olympus) and an electron-multiplying charged-coupled device (CCD) 
camera (IXON-X3; Andor Technology).
Before imaging, culture medium was replaced with prewarmed 
imaging medium, and cells were allowed to recover for 30 min at 
37°C. For the time-lapse imaging experiments, the device was mounted 
on the microscope stage, and positions of interest (in which dually in-
fected axons, UbG76V-GFP+ and VGluT1mCherry+, have crossed the 
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microgrooves into the axonal compartment) were selected. Data were 
collected sequentially from several defined positions (a maximum of 
15 per device). Focal drift during the experiment was corrected auto-
matically using the autofocus feature of the Olympus system. Laser 
intensities were kept as low as possible, and acquisition at 2 × 2 bin-
ning was performed. In experiments involving beads, three frames were 
captured of the selected positions on the axonal compartment before 
addition of beads, and then beads were added to both compartments 
(the same volume was added to both sides to prevent focus drift caused 
by unbalanced preparation). Time-lapse was resumed 10 min after 
addition of beads. Frames were acquired as z stacks (35–40 slides, 
8–10-µm range) every 10 min.
For the FM 5-95 dye experiments, each cycle of FM dye loading/
unloading comprised the following steps: FM 5-95 dye loading solution 
containing a high KCl concentration (imaging medium with 90 mM 
KCl supplemented with 10 µM FM 5-95 dye, 20 µM 6-cyano-7-nitro-
quinoxaline-2,3-dione [CNQX], and 50 µM D-AP5) to promote depo-
larization was added to microfluidic devices for 1 min and washed once 
with 10 µM FM 5-95 dye in imaging medium for 1 min. An additional 
three washes with 1  mM Advasep-7 in imaging medium, for 1 min 
each, were performed for optimal removal of FM dye excess. This me-
dium was then replaced by imaging medium containing 20 µM CNQX 
and 50 µM D-AP5, and the device was placed on the microscope stage. 
CNQX and D-AP5, which are α-amino-3-hydroxy-5-methyl-4-isoxaz-
ole propionic acid (AMPA)/kainate and N-methyl-d-aspartate (NMDA) 
receptor antagonists, respectively, were added to the medium to block 
recurrent excitation. Positive and negative electrodes were placed on 
each well of either the somal or axonal compartment, and unloading 
of the FM dye was induced by electrical stimulation, which was per-
formed by a two-channel stimulus generator (model STG4002; Multi 
Channel Systems) in current mode with an asymmetric waveform 
(−480 µA for 1 ms and 1,600 µA for 300 µs) at 20 Hz for 1,200 pulses 
for 1 min. At least four frames were acquired before stimulation. The 
frames were acquired as z stacks (35–40 slides, 8–10-µm range) every 
15 s for 5 min in a 2 × 2 binning mode. FM puncta that could unload 
>5% of their content after 1 min of electrical stimulation were consid-
ered functional presynaptic clusters (Taylor et al., 2013). For detection 
of functional FM puncta along dendrites (Fig. 5, D and E), one cycle of 
FM dye loading/unloading protocol was performed on the somal side 
of microfluidic devices after 18–20-h viral infection with the Ub con-
structs. Under the brightfield light, positions to image were carefully 
chosen to include nearly the same number of cell bodies. Dendrites 
were later detected by retrospective immunocytochemistry for MAP2.
For the experiments in which we were interested in monitoring 
the appearance of new FM puncta on beads (Fig. 1, D–G; and Fig. 4, 
E and F), beads were first added to the axonal compartment of micro-
fluidic devices and incubated for 3 h. Then, a first cycle of FM 5-95 
dye was performed, followed by complete destaining with high KCl 
imaging medium for 1 min and two washes with imaging medium 
containing 20 µM CNQX and 50 µM D-AP5. An image after FM dye 
destaining was acquired for later subtraction from the initial image of 
the second FM dye cycle. Cultures were then treated with proteasome 
inhibitors, PR619 or DMSO, for 1 h. A second cycle of FM dye with 
live-monitored unloading at exactly the same position was then per-
formed to look for the formation of new functional FM puncta. The 
position of the beads and the microgrooves were instrumental for local-
izing the imaging position between the first and second FM dye cycles.
FRAP/FLIP experiments were performed at 37°C with a con-
focal microscope (LSM 710; ZEI SS) driven by Zen Black 2012 soft-
ware (ZEI SS) with a 63× oil differential interference contrast (DIC) 
objective (M17n; NA 1.40; Plan-Apochromat) at a magnification of 2×. 
Neurons in microfluidic devices expressing UbG76V-GFP for 12 h were 
used, and imaging was performed on the axonal compartment. Medium 
was replaced for imaging medium, and beads were added to the axo-
nal compartment for 20 min before FRAP/FLIP imaging. Imaging was 
confined to the time interval between 20 min and 1 h after bead contact, 
and acquisition was done in a single z-slice manner. Bleach was accom-
plished by performing 10 bleach iterations with the 488-nm laser power 
set to 100% (100× greater than for acquisition) in a total bleach time 
of 0.45 s at 5 × 2–µm regions of interest (ROIs) carefully placed along 
axons. Before bleaching, three baseline images were taken. For FRAP, 
regions to bleach were chosen at off-bead and on-bead axonal sites. For 
the latter, a distinction was made between beads causing an increased 
intensity of UbG76V-GFP (on-bead with UbG76V-GFP increase) and the 
ones that did not alter its fluorescence along axons (on-bead without 
UbG76V-GFP increase). A minimal distance of 45 µm was maintained 
between bleached and control ROIs. After a single bleaching event, 
changes in fluorescence were analyzed at bleached and control ROIs 
every 1  s for a total of 50  s.  For FLIP, repeated bleaching was per-
formed at a 5-µm distance from the measurement site (off-bead, on-
bead with UbG76V-GFP, or on-bead without UbG76V-GFP). An image 
was taken after each bleaching episode in a total experiment time of 
130 s. Changes in fluorescence were analyzed at the bleaching region 
(FLIP ROI), at the measurement region (analysis ROI), and at regions 
of nonbleached axons (control ROI) to control for fluorescence decay 
as a result of bleaching throughout the experiment.
Immunocytochemistry
Immunocytochemistry was performed similarly to that previously 
described (Baptista et al., 2013). Cells were fixed in prewarmed 4% 
paraformaldehyde (in PBS with 4% sucrose) for 10 min at RT. A pre-
fixation of 5 min in 1% paraformaldehyde was performed to prevent 
damaging the population of isolated axons. Cultures were washed 
three times in PBS and then permeabilized in PBS with 0.25% Triton 
X-100 for 5 min at RT and washed once in PBS before blocking for 
30 min in PBS with 3% BSA. Preparations were incubated with the 
mix of primary antibodies in 3% BSA either overnight at 4°C or for 
2 h at 37°C, washed three times in PBS, and incubated with the mix 
of secondary antibodies for 1 h at RT in 3% BSA. Cultures were again 
washed, this time twice in PBS with 0.1% Triton X-100 and once in 
PBS, and the coverslip was rinsed in mQH2O and mounted in prolong 
mounting media with or without DAPI. For microfluidic chambers, the 
PDMS device was disassembled from the coverslip only before mount-
ing on the microscope glass.
Microscopy of antibody-labeled cultures
Fixed preparations were imaged using a microscope (Observer Z.1; 
ZEI SS) equipped with a 63× oil objective (1.4 NA; Plan-NeoFluar), 
a CCD digital camera (AxioCam HRm), and the Zen Blue 2011 soft-
ware (ZEI SS). In microfluidic devices, unless otherwise indicated, 
images were taken of the axonal compartment. XY reconstructions 
of microfluidic devices (with both somal and axonal compartments) 
were performed either with a confocal microscope (LSM 510 Meta; 
ZEI SS) with a 40× objective (1.3 NA; DIC M27; EC-PlanNeofluar) 
driven by the LSM 510 software or a spinning disk confocal imaging 
system (CSU-X1-M1N-E; Yokogawa Electric Corporation) configured 
for a microscope (IX81; Olympus) driven by Andor iQ 3.1 software 
with a 60× water objective (1.2 NA; UPL SAPO; Olympus) and an 
electron-multiplying CCD camera (IXON-X3; Andor Technology). 
Posthoc immunocytochemistry after live experiments was performed 
using the spinning disk system. In these preparations, the device was 
not disassembled after immunocytochemistry, and retrospective im-
aging was performed in PBS using the 60× water objective. This al-
lowed us to easily locate the multiple positions where live data were 
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collected by using the microgrooves as coordinates. In brief, micro-
grooves were numbered according to the orientation of the device on 
the microscope stage, and at the end of acquisition, each position of the 
microgroove nearer to its center was marked down. The position was 
then corrected manually by comparing the DIC image acquired at the 
end of the live experiment with that of the fixed preparation. Moreover, 
the plug-in Align images by line ROI in ImageJ was further used to 
guarantee perfect alignment.
Quantitative imaging analysis
Quantification of fluorescence images was performed using ImageJ 
software (National Institutes of Health). For fixed cells, samples within 
an experiment were simultaneously stained and imaged with identical 
settings (exposure time and fluorescence light intensity were kept con-
stant throughout acquisition). Images of random fields of view (FOVs) 
of either isolated axons or cell bodies were taken. Selection of ROIs 
to acquire fluorescent images was performed either on the axonal or 
somal marker to avoid bias acquisition. All images were converted to 
8 bit for quantification purposes.
To quantify the number of presynaptic puncta along axons, the 
axonal marker image was used to select populations of axons to quan-
tify. Axonal length was determined by performing analysis (ImageJ 
plug-in Analyze skeleton) of a “skeletonized” version of the axonal 
marker. The sum of the length of all the axonal branches identified 
in an image was used as the axonal length. Correspondent images 
of synaptic markers were thresholded (threshold values conserved in 
individual experiments), and particle analysis was performed to cal-
culate number and area of puncta. To quantify the number of pre-
synaptic clusters (Bassoon-VGluT1 clusters), the presence or absence 
of VGluT1 puncta within Bassoon puncta ROIs was determined, and 
the total number of Bassoon ROIs containing VGluT1 puncta was di-
vided by the axonal length. Analysis was limited to Bassoon puncta 
bigger than the smaller quantifiable object (0.05 µm2) in accordance 
with our imaging settings (Waters, 2009) in order to exclude the 
possible contribution of mobile piccolo-Bassoon transport vesicles 
(0.02 µm2; Zhai et al., 2001; Shapira et al., 2003), thus narrowing 
down analysis to nascent presynaptic sites. A minimum of 12 micro-
scope FOVs of the axonal side were analyzed per individual exper-
iment in each condition.
For quantification of live experiments, confocal slices were sum 
projected in ImageJ, and alignment of frames within each video was 
performed by TurboReg or StackReg plug-ins and converted to 8 bit. 
In experiments involving accumulation of synaptic material on beads, 
analysis was performed similarly to a study by Lucido et al. (2009). 
The brightfield image was used to locate beads in contact with axons, 
and ROIs for individual beads and adjacent sites along the axon were 
created (on-bead and off-bead, respectively). Change in signal was 
quantified by measuring the fluorescence intensity at each bead and 
correspondent off-bead site in each individual frame of the time-lapse 
video. Individual values were then normalized to the fluorescence in-
tensity in that site at the frame preceding addition of beads (time 0, 0 
min) both for on-bead and off-bead sites.
For the experiment in which formation of presynaptic clusters 
on dendrites was monitored (Fig. 3, A–F), digital videos of the time-
lapse sequence for each position were prepared and carefully analyzed 
to detect formation of stable VGluT1mCherry clusters in sites not de-
tected at prior time points (“new”) or clusters stable at approximately 
the same location throughout the entire time-lapse (“old”). Puncta were 
only considered new if stable until the end of the time-lapse for at 
least 30 min. After identification of new and old puncta, their locations 
were overlaid on the corresponding posthoc MAP2 immunostained 
images (see Microscopy of antibody-labeled cultures for further de-
tails on acquisition of images after retrospective labeling). Alignment 
of VGluT1mCherry and UbG76V-GFP videos with MAP2 retrospective 
ones was done according to the brightfield images of the same region 
taken at the end of the time-lapse and the one after immunostaining by 
the ImageJ plug-in Align images by line ROI. The alignment correction 
used for DIC images was applied to VGluT1mCherry and UbG76V-GFP, 
and new and old VGluT1mCherry clusters formed onto dendrites 
were considered. ROIs encompassing the whole VGluT1mCherry 
cluster were created at the site of clustering (on-site) and equal-sized 
ROIs at adjacent axonal sites (off-site; Fig. 3, A and B, on-site and off-
site correspond to dashed and solid boxes, respectively). Change in sig-
nal was quantified by measuring the fluorescence intensity at each ROI 
in each individual frame of both VGluT1-mCherry and UbG76V-GFP 
time-lapse videos and used to generate the dataset presented in Fig. 3 
(E and F). For VGluT1mCherry, individual values were normalized to 
the fluorescence intensity in that site at time 0. For new and old puncta, 
time 0 is considered to be the frame before clustering was initiated 
or the first frame of the time-lapse, respectively. For new puncta, we 
considered the beginning of clustering as the frame at which the stable 
puncta first appeared, recognized as a high increase in fluorescent sig-
nal (at least a 30% increase in signal intensity in relation to the previous 
frame). For UbG76V-GFP, the ratio of its intensities between the on- and 
off-site was calculated.
For the FM dye experiments, the brightfield image was used to 
create ROIs encompassing beads or dendrites that contact with axons. 
Then, the number of FM puncta on each bead or along each dendritic 
segment was quantified by performing particle analysis in ImageJ. 
To evaluate the unloading capacity of FM puncta, quantification was 
adapted from previous work (Taylor et al., 2013). Each puncta inten-
sity is measured throughout the registered sequence of images (frames 
every 15 s for 5 min), normalized to the frame before stimulation, and 
corrected for the baseline slope (calculated from the change in intensity 
in the three frames preceding stimulation). Puncta that unloaded >5% 
of their FM dye content after 1 min of stimulation were considered 
as functional (Taylor et al., 2013). For the experiment with a double 
FM dye cycle (Fig. 1, D–G; and Fig. 4, E and F), the net gain in func-
tional and total FM puncta was calculated by subtracting the number of 
puncta after and before treatment.
For quantification of axonal volume, 0.23-µm–spaced z stacks 
were acquired from mApple-expressing axons in the axonal com-
partment. Volume at designated ROIs was quantified with the ImageJ 
plug-in 3D object counter (Bolte and Cordelières, 2006), which de-
termines the number of voxels in an object and calibrates it into xyz 
dimensions, with the threshold kept constant between on-bead and the 
adjacent ROI. 3D surface reconstructions were obtained in ImageJ with 
the plug-in ImageJ 3D viewer.
For FRAP and FLIP, change in fluorescence at designated ROIs 
was obtained from the sequence of images, and values were normalized 
to the frame preceding bleaching. For quantification of FRAP experi-
ments, data for each FRAP event were fitted to a one-phase exponential 
association function (y = y0 + [plateau − y0] × [1 − exp(−x/τ)], with 
y0 constrained to between 0 and 1) in Prism 5 (GraphPad Software). 
Individual values of the plateau and time constant (τ) were obtained for 
each curve fitting and compared. The recovery fraction was calculated 
as equal to the plateau × 100 (Fig. 2 F). For FLIP experiments, data for 
each FLIP event were fitted to a one-phase exponential decay function 
(y = [y0 − plateau] × exp[−x/τ] + plateau, with y0 constrained to be-
tween 0 and 1) in Prism 5 software. Individual values of the plateau 
and time constant (τ) were obtained for each curve fitting. The retained 
fraction was calculated as equal to (1 − plateau) × 100 (Fig. 2 I, left).
All images were processed and prepared for presentation using 
Photoshop (Adobe). Figures were created in Illustrator (Adobe).
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Statistical analysis
Results are presented as mean values ± SEM. Graphs and statistical 
analysis were performed in Prism 5 software. Statistical significance 
was assessed by nonparametric tests. Mann-Whitney test or Wilcoxon 
paired t test was performed for comparisons of changes between two 
groups. For comparisons between multiple groups, we used the Kruskal- 
Wallis test followed by the Dunn’s multiple comparison test. For the 
live-imaging data, we performed two-way analysis of variance (ANO 
VA) with time as the repeated measure to assess changes between two 
groups throughout time.
Online supplemental material
Fig. S1 provides control experiments validating the specific inhibition 
of the proteasome in isolated axons and its synaptogenic effect. 
Fig. S2 gathers additional information that supports a decreased 
proteasome activity at sites of newly formed presynaptic clusters. Fig. 
S3 provides supporting information for the triggering of presynaptic 
assembly by proteasome-related ubiquitinated conjugates. Online 
supplemental material is available at http ://www .jcb .org /cgi /content /
full /jcb .201509039 /DC1.
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